Yi Qi Cong Ming Tang
Natural health product licensed in Canada
- Other names
- Ginseng, Astragalus & Pueraria Combination
- Licence holder
- STPCA dba Sun Ten Laboratories
- NPN or DIN-HM
- 80101009
- Status
- Active licence
- Licence date
- 28 May 2020
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phellodendron chinense Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 200 mg | 42.22 mg | Not calculated |
| Glycyrrhiza uralensis Source : Racine Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 100 mg | 21.11 mg | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 500 mg | 105.56 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 500 mg | 105.56 mg | Not calculated |
| Actaea dahurica Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 150 mg | 31.665 mg | Not calculated |
| Pueraria montana var. lobata Source : Racine Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 300 mg | 63.33 mg | Not calculated |
| Vitex trifolia Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 300 mg | 63.33 mg | Not calculated |
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 4.737:1 Dry plant equivalent : 200 mg | 42.22 mg | Not calculated |
Non-medicinal ingredients
Cellulose en poudre, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 4 Portion(s) | 3 Tous les jours |
Uses authorised in Canada
Product based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80101009
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.